A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Stem cells are undifferentiated cells capable of both self-renewal (producing more stem cells) and differentiation (producing specialized cell types). They exist in a hierarchy of potency: totipotent (zygote — can form entire organism), pluripotent (embryonic stem cells — can form all cell types of the body), multipotent (adult tissue stem cells — restricted to cell types within their lineage), and unipotent (producing only one cell type). Adult stem cells reside in specialized microenvironments called niches that balance self-renewal and differentiation signals. Stem cell biology bridges developmental biology, regenerative medicine, and cancer research — cancer stem cells may hijack normal stem cell self-renewal mechanisms.
Every tissue in the adult body faces a fundamental challenge: maintaining function despite continuous cell loss. The gut epithelium replaces its entire lining every 3-5 days. Blood cells have lifespans ranging from hours (neutrophils) to months (red blood cells). Skin is continuously shed. This constant turnover requires an ongoing source of new cells — and that source is stem cells. Understanding how stem cells balance self-renewal (making more stem cells) and differentiation (making specialized cell types) is central to developmental biology, regenerative medicine, and cancer research.
Stem cells are defined by two functional properties: self-renewal (the ability to divide and produce at least one daughter cell that retains stem cell identity) and differentiation (the ability to produce specialized, functionally mature cell types). The potency of stem cells — how many different cell types they can produce — forms a hierarchy. Embryonic stem cells (ESCs), derived from the inner cell mass of the blastocyst, are pluripotent: they can form any cell type in the body (all three germ layers and their derivatives). Adult tissue stem cells are more restricted: hematopoietic stem cells produce all blood cell types (multipotent), intestinal stem cells produce the four epithelial cell types of the gut, and satellite cells in muscle produce only skeletal muscle fibers.
The behavior of tissue stem cells is not cell-autonomous — it is controlled by the niche, a specialized microenvironment that provides the signals necessary to maintain stem cell identity. The intestinal stem cell niche, for example, consists of Paneth cells at the base of crypts that produce Wnt ligands (promoting self-renewal), surrounding mesenchymal cells that produce BMP antagonists (preventing premature differentiation), and extracellular matrix that anchors stem cells in position. When a stem cell divides, the daughter that stays in the niche retains stem cell identity (bathed in niche signals); the daughter that moves out of the niche loses those signals and begins to differentiate. This elegant spatial mechanism converts stem cell division into an asymmetric outcome without requiring intrinsic asymmetric division machinery.
The connection to cancer is direct and consequential. Many of the signaling pathways that maintain normal stem cell self-renewal — Wnt, Notch, Hedgehog — are frequently mutated in cancer, and constitutive activation of these pathways can give cancer cells unlimited self-renewal capacity. The cancer stem cell hypothesis proposes that within a heterogeneous tumor, only a small subpopulation of cells with stem-like self-renewal capacity can sustain long-term tumor growth. If true, this has profound therapeutic implications: conventional chemotherapy may shrink the bulk tumor without eliminating the cancer stem cells, allowing regrowth. Targeting the self-renewal mechanisms specifically — Wnt inhibitors, Notch inhibitors — is an active area of drug development, constrained by the challenge of disrupting cancer stem cell self-renewal without damaging normal tissue stem cells that use the same pathways.